Skip to main content

Nasdaq IPOs

Cancer biotech Immunocore prices upsized US IPO above the range at $26

5 years 7 months ago
Immunocore Holdings, a Phase 3 biotech developing T cell therapies for cancer and other diseases, raised $258 million by offering 9.9 million ADSs at $26, above the range of $23 to $25. The company offered 19% more ADSs than anticipated at $26 based on an F-1MEF filing late Thurs
Renaissance Capital

Cancer biotech Immunocore prices upsized IPO above the range at $26

5 years 7 months ago
Immunocore Holdings, a Phase 3 biotech developing T cell therapies for cancer and other diseases, raised $258 million by offering 9.9 million ADSs at $26, above the range of $23 to $25. The company offered 19% more ADSs than anticipated at $26 based on an F-1MEF filing late Thurs
Renaissance Capital

NASH biotech Terns Pharmaceuticals prices upsized IPO at $17 high end

5 years 7 months ago
Terns Pharmaceuticals, a Phase 2 biotech developing small molecule therapies for NASH, raised $128 million by offering 7.5 million shares at $17, the high end of the range of $15 to $17. The company offered 1.3 million more shares than anticipated. At pricing, Terns commands a fu
Renaissance Capital

PropTech-focused SPAC BOA Acquisition files for a $175 million IPO

5 years 7 months ago
BOA Acquisition, a blank check company targeting real estate technology, filed on Thursday with the SEC to raise up to $175 million in an initial public offering. The Washington, DC-based company plans to raise $175 million by offering 17.5 million units at $10. Each unit will c
Renaissance Capital

Brazil-focused SPAC Itiquira Acquisition prices $200 million IPO

5 years 7 months ago
Itiquira Acquisition, a blank check company targeting growth sectors in Brazil, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. SPX Equities Gestão de Recur
Renaissance Capital

Smart tech SPAC Novus Capital Corp II prices $250 million IPO

5 years 7 months ago
Novus Capital Corp II, a blank check company targeting businesses enabling smart technology evolution, raised $250 million by offering 25 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company is
Renaissance Capital
Checked
25 minutes 53 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed